Use of the solubility parameter and surface energy concepts in the formulation of solid dosage forms

被引:0
|
作者
Barra, J
Bustamante, P
Doelker, E
机构
[1] Univ Geneva, Sch Pharm, CH-1211 Geneva 4, Switzerland
[2] Univ Alcala de Henares, Dept Pharm & Pharmaceut Technol, Madrid 28871, Spain
来源
STP PHARMA SCIENCES | 1999年 / 9卷 / 04期
关键词
solubility parameters; surface energies; particle size; blending; granulation; tabletting; coating; solid dosage forms;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This review presents some theoretical notions on both the solubility parameter and surface energy concepts, including the different models and the power laws relating them as well as the methods of determination (experimental calculation). Subsequently, we describe the parameters derived from solubility parameters and surface energies (interfacial tension, spreading coefficient, interaction parameter, strength of interaction). The theoretical potential of these parameters is outlined along with practical uses published in the literature. The applications include all the major steps involved in the preparation of solid dosage forms, such as prediction of the organization of powder mixes during blending, estimation of binder efficiency in granulation, modification of the powder surface energy to change the tensile strength of tablets, and optimization of the interaction of plasticizers with coating polymers. Finally, a general approach taking particle size into account is proposed, and the consequences for blending (organization, colour and taste) and compactibility are outlined.
引用
收藏
页码:293 / 305
页数:13
相关论文
共 50 条
  • [1] Use of poloxamers in the formulation of innovative oral solid dosage forms
    Laverty, T.
    Jones, D.
    Andrews, G.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2006, 58 : A79 - A79
  • [2] Formulation and Manufacturing of Solid Dosage Forms
    Qi Tony Zhou
    Tonglei Li
    Pharmaceutical Research, 2019, 36
  • [3] Formulation and Manufacturing of Solid Dosage Forms
    Zhou, Qi Tony
    Li, Tonglei
    PHARMACEUTICAL RESEARCH, 2019, 36 (01)
  • [4] Formulation and characterization of glipizide solid dosage form with enhanced solubility
    Alotaibi, Badriyah Shadid
    Khan, Muhammad Ahsan
    Ullah, Kaleem
    Yasin, Haya
    Mannan, Abdul
    Khan, Shujaat Ali
    Murtaza, Ghulam
    PLOS ONE, 2024, 19 (02):
  • [5] SHOULD MAGNESIUM STEARATE BE ASSESSED IN THE FORMULATION OF SOLID DOSAGE FORMS BY WEIGHT OR BY SURFACE-AREA
    FRATTINI, C
    SIMIONI, L
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1984, 10 (07) : 1117 - 1130
  • [6] FORMULATION OF ORAL, LONG-ACTING, SOLID, DOSAGE FORMS
    DELPORTE, JP
    FARMACO-EDIZIONE PRATICA, 1974, 29 (08): : 407 - 432
  • [7] Optimization of the formulation of solid multiparticulate dosage forms containing pancreatin
    Kristo, Katalin
    Bajdik, Janos
    Pintye-Hodi, Klara
    CHEMICAL ENGINEERING RESEARCH & DESIGN, 2010, 88 (8A): : 1033 - 1036
  • [8] FORMULATION OF KETOROLAC TROMETHAMINE IN SEMI-SOLID DOSAGE FORMS
    Habib, Fawzia
    Azeem, Maha Abdel
    Fadl, Amal El Sayeh
    El Sayed, Raafat
    BULLETIN OF PHARMACEUTICAL SCIENCES, 2009, 32 : 257 - 271
  • [9] Solid Dosage Forms of Dexamethasone Sodium Phosphate Intended for Pediatric Use: Formulation and Stability Studies
    Synaridou, Maria S.
    Andriotis, Eleftherios G.
    Zacharis, Constantinos K.
    Fatouros, Dimitrios G.
    Markopoulou, Catherine K.
    PHARMACEUTICS, 2020, 12 (04)
  • [10] VALUE OF PHYSICAL TESTING DURING FORMULATION OF SOLID DOSAGE FORMS
    TRAISNEL, MM
    PHARMACY INTERNATIONAL, 1981, 2 (07): : AB12 - AB12